BioSig Technologies, Inc.

  • Home
  • About BioSig
    • Overview
    • Leadership
    • Bioelectronic Medicine
    • Partnerships
  • Pure EP
    • Our Solution
    • Publications
    • Physician Insights
  • Join Our Team
    • Join Our Team
    • Working at Biosig
    • Discover Your Potential
  • News & Media
    • Overview
    • Press Releases
    • BioSig in the News
    • Presentations
    • Events
    • CEO Blog
    • Newsletter
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • NeuroClear
  • Contact
Investors

Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Fact Sheet
    • Contacts
    • RSS News Feed

Press Releases

  • News / Events

  • Press Releases
  • IR Calendar
  • Email Alerts

BioSig Announces Pricing of Public Offering of Common Stock

June 24, 2022

BioSig Announces Proposed Public Offering of Common Stock

June 23, 2022

BioSig Announces New Evaluation Agreement for its PURE EP System with Cleveland Clinic

June 22, 2022

BioSig Advances its PURE™ System Commercial Launch to Medical Centers Nationwide

May 26, 2022

BioSig’s PURE EP™ System to be Featured During EPLive 2022

May 25, 2022

BioSig Technologies, Inc. Issues Shareholder Letter with Corporate Update on Recent Achievements

May 11, 2022

BioSig to Present at Heart Rhythm 2022

April 19, 2022

BioSig to Present at NobleCon18 Capital Markets Conference

April 7, 2022

BioSig Technologies, Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services

March 29, 2022

BioSig Announces Closing of Public Offering of Common Stock

March 23, 2022
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...30
Award
BioSig Technologies, Inc.
Sign Up for BioSig Updates Contact Us
Twitter linkedin Facebook
© 2022 BioSig Technologies, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap